<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://repository.usmf.md:80/handle/20.500.12710/15877">
    <title>DSpace Collection:</title>
    <link>http://repository.usmf.md:80/handle/20.500.12710/15877</link>
    <description />
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="http://repository.usmf.md:80/handle/20.500.12710/16915" />
        <rdf:li rdf:resource="http://repository.usmf.md:80/handle/20.500.12710/16054" />
        <rdf:li rdf:resource="http://repository.usmf.md:80/handle/20.500.12710/16040" />
        <rdf:li rdf:resource="http://repository.usmf.md:80/handle/20.500.12710/16039" />
      </rdf:Seq>
    </items>
    <dc:date>2026-04-12T04:17:45Z</dc:date>
  </channel>
  <item rdf:about="http://repository.usmf.md:80/handle/20.500.12710/16915">
    <title>The Moldovan Medical Journal. March 2021, Vol. 64, No 1</title>
    <link>http://repository.usmf.md:80/handle/20.500.12710/16915</link>
    <description>Title: The Moldovan Medical Journal. March 2021, Vol. 64, No 1
Abstract: The Moldovan Medical Journal is an international scientific double-blind peer-reviewed periodical edition, 4 per year, of the&#xD;
Scientific Medical Association of the Republic of Moldova designed for specialists in the areas of medicine, dentistry, pharmacy,&#xD;
social medicine, and public health. From its debut, the journal has striven to support the interests of Moldovan medicine concerning the new concepts of its development.&#xD;
The Editorial Board warmly welcomes both the readers of and the authors of the journal, all those who are enthusiastic about&#xD;
searching for new and more effective ways of solving numerous medical problems. We hope that those who want to make their&#xD;
contribution to the science of medicine will find our journal helpful and encouraging.
Description: Founder: The Scientific Medical Association of the Republic of Moldova</description>
    <dc:date>2021-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://repository.usmf.md:80/handle/20.500.12710/16054">
    <title>Angioarchitecture of the major duodenal papilla and its relevance for endoscopic sphincterotomy</title>
    <link>http://repository.usmf.md:80/handle/20.500.12710/16054</link>
    <description>Title: Angioarchitecture of the major duodenal papilla and its relevance for endoscopic sphincterotomy
Authors: Pitel, Eleferii; Suman, Serghei; Gutu, Evghenii
Abstract: Abstract.&#xD;
Background: The advantages of endoscopic retrograde cholangiopancreatography (ERCP) over traditional surgery for correction of various biliary and&#xD;
pancreatic pathologies became apparent immediately after its introduction into large clinical practice and today are also not in doubt. ERCP and endoscopic&#xD;
sphincterotomy (EST) are characterized by efficacy similar to open surgery, but significantly less traumatic, relatively easy, a decrease in the degree of&#xD;
perioperative surgical and anesthetic risk, and a reduction in the time of in-hospital treatment and postoperative recovery. However, therapeutic ERCP&#xD;
with EST can be complicated by gastrointestinal bleeding, the degree of which can range from mild to very severe and even life-threatening. Although&#xD;
the greatest risk for the development of bleeding after EST is caused by preexisting coagulopathy, the anatomical features of the arterial blood supply to&#xD;
the pancreaticoduodenal region and major duodenal papilla should also be taken into account during the endoscopic procedure.&#xD;
Conclusions: The communicating artery, directly vascularizing the area of the major duodenal papilla, usually originates from the posterior superior&#xD;
pancreaticoduodenal artery and entering in the anterior pancreaticoduodenal arcade. The smallest number of papillary arteries, distributed in potential&#xD;
accessibility to the sphincterotomy incision, is located in the zone between 10 and 11 o’clock of the papilla Vater circumference. Hence, the preferred&#xD;
performance of EST in this area can be accompanied by a significant reduction in the risk of arterial bleeding after ERCP.
Description: Medical Center Sanatate of Minimally Invasive Surgery and Echography, Chisinau, the Republic of Moldova, Department of Anatomy and Clinical Anatomy, Department of General Surgery,&#xD;
Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, the Republic of Moldova</description>
    <dc:date>2021-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://repository.usmf.md:80/handle/20.500.12710/16040">
    <title>Diagnostic markers of urinary bladder tumors</title>
    <link>http://repository.usmf.md:80/handle/20.500.12710/16040</link>
    <description>Title: Diagnostic markers of urinary bladder tumors
Authors: Vladanov, Ivan; Pleșacov, Alexei; Colta, Artur; Ghicavii, Vitalii
Abstract: Abstract.&#xD;
Background: The perfect method for laboratory diagnosis of bladder cancer should have high sensitivity and specificity, should be easily reproducible,&#xD;
inexpensive, be suitable for primary diagnosis, screening, and follow-up of patients, for timely detection of recurrence. In clinical practice, for bladder&#xD;
cancer diagnostics have been used the following markers: UBC, BTA, “ImmunoCyt”, NMP22, “UroVision», and others. Each method has relative&#xD;
advantages and disadvantages. The study has demonstrated an influence on the test result of the histological structure and grade of the tumor, presence&#xD;
of hematuria, urolithiasis, chronic inflammatory malignancies, recent surgical procedures on the urinary tract. Apparently, the use of a palette of markers&#xD;
in connection with imaging techniques will increase the diagnostic capabilities, but it is still not clear which elements should be present in such a palette.&#xD;
Conclusions: At present, basic diagnostic methods for bladder cancer remain: USG, MRI, CT, and endoscopic methods. The laboratory methods that&#xD;
exist are not informative enough. Each marker has serious restrictions, but possibly the complex application will allow increasing the diagnostic value in&#xD;
the future, therefore it is necessary to develop new markers of bladder cancer or to study the results of the complex application of several known markers&#xD;
to increase the value of the laboratory diagnosis of primary bladder cancer and recurrent.
Description: Department of Urology and Surgical Nephrology,&#xD;
Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, the Republic of Moldova</description>
    <dc:date>2021-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://repository.usmf.md:80/handle/20.500.12710/16039">
    <title>Predictive molecular markers of resistance to chemotherapy in breast cancer</title>
    <link>http://repository.usmf.md:80/handle/20.500.12710/16039</link>
    <description>Title: Predictive molecular markers of resistance to chemotherapy in breast cancer
Authors: Cucieru, Valerian
Abstract: Abstract.&#xD;
Background: Breast cancer is one of the three most common cancers along with lung and colon cancer. It is a leading cause of cancer deaths in both&#xD;
developing and developed countries. Within 2 decades, neoadjuvant chemotherapy (NAC) has become a standard treatment option in breast cancer.&#xD;
Relevant articles were identified by means of PubMed, Embase, Web of Science, Cochrane Library, and Springer Link databases published during the&#xD;
years 2010-2019, describing the role of molecular biomarkers in the assessment of NAC for breast cancer.&#xD;
Conclusions: The size of the breast primary tumor, the affection of the regional lymph nodes, the degree of tumor differentiation, the expression of&#xD;
hormone receptors, HER2neu, ki67 serve as the main criteria for predicting the response to NAC. Preoperative core needle biopsy is the gold standard&#xD;
procedure in cancer diagnostics, in the analysis of predictive biomarkers, particularly utilizing histomorphological characteristics. Carrying out a larger&#xD;
number of cycles of NAC as well as correlating the schemes in relation to the immunohistochemical types have a direct influence on obtaining a good&#xD;
response to treatment. Patients with a pathological complete response had superior survival outcomes compared with patients who had residual disease.
Description: Department of Breast Cancer, Institute of Oncology, Chisinau, the Republic of Moldova</description>
    <dc:date>2021-01-01T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

